Sunflower Pharmaceutical Group Co.,Ltd (SHE:002737)

China flag China · Delayed Price · Currency is CNY
13.68
+0.05 (0.37%)
Mar 10, 2026, 3:04 PM CST
-23.15%
Market Cap 7.99B
Revenue (ttm) 2.09B
Net Income (ttm) -128.33M
Shares Out 584.00M
EPS (ttm) -0.23
PE Ratio n/a
Forward PE n/a
Dividend 0.50 (3.67%)
Ex-Dividend Date Jul 18, 2025
Volume 2,286,604
Average Volume 2,609,994
Open 13.42
Previous Close 13.63
Day's Range 13.42 - 13.71
52-Week Range 13.36 - 19.01
Beta 0.24
RSI 33.33
Earnings Date Apr 27, 2026

About SHE:002737

Sunflower Pharmaceutical Group Co.,Ltd engages in the research and development, manufacturing, and marketing of Chinese patent medicines in China and internationally. The company produces chemical and biological medicines, and health care products. It also provides products covering various therapeutic areas, including pediatrics, gynecology, adult digestive system, respiratory and cold, rheumatic bone disease, and cardiovascular and cerebrovascular; supplements; tonic; and antibiotics and children’s medicinal products. The company sells its pr... [Read more]

Sector Healthcare
Founded 2005
Employees 5,727
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002737
Full Company Profile

Financial Performance

In 2024, SHE:002737's revenue was 3.38 billion, a decrease of -40.76% compared to the previous year's 5.70 billion. Earnings were 492.05 million, a decrease of -56.03%.

Financial Statements

News

There is no news available yet.